Navigation Links
FDA approves surgical gel

The Food and Drug Administration (FDA) approved a gel that promises less internal scarring for women undergoing certain surgeries. The FDA had initially rejected Lifecore Biomedical Inc.'s Intergel, which promises to reduce internal scarring from certain gynecologic operations. //

The gel, formally named Gynecare Intergel Adhesion Prevention Solution, is intended to reduce adhesions, internal scar tissue that can cause chronic pain or intestinal obstruction. Various adhesion-preventing treatments already are sold, but Intergel is the first liquid one.

It is only for use during open gynecologic operations -- not the increasingly common "keyhole" surgeries where doctors operate through a small incision, the FDA warned. Nor is it for women with abdominal or pelvic infection, or who have cancer or are pregnant. The manufacturers would begin selling Intergel in February and cost about $200.


'"/>




Page: 1

Related medicine news :

1. FDA approves new device to treat womens bleeding disorder
2. FDA approves drug for rare liver disease
3. FDA approves first pocket-sized EKG machine
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. New spray gel heals surgical wounds
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... 2017 , ... Doctors on Liens has added the medical group Bones and ... on a personal injury lien basis. Founded by Dr. Wayne Cheng, MD and Dr. ... experience with orthopedic injuries to patients in the Inland Empire. , Bones and Spines ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part ... company recently unveiled a redesigned website. The new site – still located at ... owners, architects, contractors and other industry users that Garland serves. , After an ...
(Date:9/20/2017)... AZ (PRWEB) , ... September 20, 2017 , ... Five ... in innovation and market impact in 27 different categories. Nopavera Plus was ... each category will be announced at SupplySide West 2017 during presentations at SupplySide Central ...
(Date:9/20/2017)... ... , ... “The Trials I Face to Receive God’s Grace”: a mesmerizing ... and goals to better one’s life through God. “The Trials I Face to Receive ... the wrong places, found a love for writing. Green feels that expressing his feelings ...
(Date:9/20/2017)... ... , ... “Psalms of Humidity”: is a fascinating depiction of daily struggles and ... step closer to God. “Psalms of Humidity” is the creation of published author, David ... within his life are the very same things that have shaped him into the ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... 18 months after its February 2016 launch, market access ... of three new senior people to its rapidly expanding ... and James Wright bring decades of specialist ... Tammy Wynne joins as Director, Value Communication, ... over ten years, experience in global market access consultancy ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will present at ... 2017, in New York . John ... to present at 11:05 a.m. Eastern Time. ... . A recorded replay will be available one hour after ... About Hill-Rom Holdings, ...
Breaking Medicine Technology: